Parasite Antibodies & Antigen Reagents | Helminths & Protozoa

Research-grade reagents for malaria and parasitic disease research — primarily targeting Plasmodium species (P. falciparum, P. vivax, P. berghei), with additional coverage of Cryptosporidium, Toxoplasma, Trypanosoma, and Opisthorchis. Our portfolio includes recombinant antibodies against key vaccine and blood-stage antigens (CSP, MSP, PfEMP1, VAR2CSA), InVivoMAb functional-grade clones for in vivo transmission-blocking studies, and His-tagged recombinant proteins for immunization and assay development. RUO

Why Researchers Choose abinScience

CSP & Transmission-Blocking ReagentsAnti-CSP recombinant antibodies (9 clones) targeting P. falciparum and P. berghei circumsporozoite protein, validated for ELISA and neutralization. Anti-Pvs25 and anti-PF45/48 InVivoMAb clones for transmission-blocking vaccine research.

Blood-Stage & Cytoadherence TargetsAntibodies and recombinant proteins for merozoite invasion (MSP1, MSP2) and erythrocyte cytoadherence (PfEMP1, VAR2CSA) research. P. vivax reticulocyte-binding protein RBP2b antibodies and recombinant antigens also available.

InVivoMAb Functional-Grade (4)Low-endotoxin, azide-free antibodies for in vivo malaria studies. Includes anti-Pvs25, anti-RBP2b, and anti-PF45/48 clones with validated neutralization and blocking activity for transmission-blocking and invasion-inhibition experiments.

Additional Parasite TargetsAnti-Cryptosporidium parvum antibodies (CSL, GP25-200, CPS-500 antigens) validated for ELISA and WB. Anti-Toxoplasma gondii SAG1 antibody and recombinant protein. Anti-Trypanosoma cruzi trans-sialidase and anti-Opisthorchis viverrini paramyosin clones.

All products manufactured by AtaGenix Laboratories under ISO 9001 & ISO 13485 quality systems.